Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study
Authors:
- 19 January 2012
- journal article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 23 (3) , 455-462
Abstract
The majority of data on risk factors (RFs) for hepatocellular carcinoma (HCC) comes from studies involving populations without underlying liver disease. It is important to evaluate RFs for HCC in patients with chronic liver disease since HCC rarely occurs in those without underlying liver disease. We conducted a hospital-based case–control study of 259 incident HCC cases and 781 controls by convenience sampling between 02/2001 and 12/2009 from the liver clinic at Stanford University Medical Center. The study population was 41% White, 14% Hispanic, 3% African American, 40% Asian American, and 2% other race/ethnicity. RFs were examined through medical records and an in-person questionnaire. Alcohol and tobacco use was calculated by cumulative grams of alcohol or cumulative pack(s) of cigarette consumed over one’s lifetime. Diabetes mellitus (DM) was defined by random glucose level of ≥200 mg/dL. RFs were evaluated using multivariate logistic regression. Independent predictors of HCC risk, after mutual adjustment and additional control for alcohol use, etiology of liver diseases, and DM, included age >40 (OR = 8.5 [2.6–28.3]), male gender (OR = 3.5 [2.2–5.8]), presence of cirrhosis (OR = 2.8 [1.6–4.9]), Asian ethnicity (OR = 2.8 [1.8–4.6]), AFP > 50 (OR = 4.2 [2.6–6.8]), and cumulative lifetime tobacco use of >11,000 packs (OR = 1.7 [1.0–2.9]). Heavy prolonged cigarette smoking, but not alcohol use, was a significant independent predictor for HCC in patients with underlying liver disease. Besides older age, male gender, presence of cirrhosis, and elevated AFP, Asian ethnicity and heavy cumulative tobacco use are strong independent predictors of HCC.Keywords
This publication has 28 references indexed in Scilit:
- Hepatocellular cancer care: Cost is important but only one factor of disease burdenJournal of Hepatology, 2009
- Hepatocellular carcinoma: Epidemiology and clinical aspectsMolecular Aspects of Medicine, 2008
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesisWorld Journal of Gastroenterology, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- General managementBest Practice & Research Clinical Gastroenterology, 2005
- Hepatocellular carcinoma: Recent trends in the United StatesGastroenterology, 2004
- Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic statusAmerican Journal of Gastroenterology, 2003
- Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and WomenAmerican Journal of Epidemiology, 2002
- Global cancer statistics in the year 2000The Lancet Oncology, 2001